BDNF and progressive pseudorheumatoid arthropathy of childhood: This conclusion is supported by existing research, including studies on the effects of treatments like Timosaponin B-III, selective serotonin reuptake inhibitors (SSRIs), and progesterone therapy on PPD models, which have highlighted abnormalities in BDNF and synapse-related protein expression [46–48].